Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference

WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, at 10:30 a.m. (EST). You can access the webcast of the presentation via the Investors section... Read more

Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio

Delivers Simultaneous Multi-Region Neural Imaging of Free-Behaving Animals BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the signing of the definitive agreement to purchase 100% of the shares of Neurescence Inc., an innovative provider of ultralight fiber-bundle Multiscopes™ for simultaneous multi-region, optical functional neuroimaging. Neurescence’s flagship product Chromatone™ moves illumination and detection hardware off... Read more

Bruker Announces Quarterly Dividend

BILLERICA, Mass–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on December 16, 2022 to stockholders of record as of December 1, 2022. About Bruker Corporation... Read more

Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases

WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. About Thermo Fisher Scientific Thermo Fisher... Read more

Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation

Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation WASHINGTON, Nov. 10, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation. Danaher Beacons is a... Read more

Bruker Announces Acquisition of Inscopix for Neuroscience Research

Head-Mounted Miniscopes Expand Neural Functional Imaging Capabilities MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Inscopix, Inc., a neuroscience pioneer and market leader of miniaturized microscopes, known as miniscopes, for freely moving animal brain imaging. Since its founding in 2011, Inscopix’s flagship miniscope systems have been deployed in over 600... Read more